Cosmo Pharmaceuticals NV (CMOPF)

158.04 -0.96 (-0.60%) USD  |  OTCM  |  Feb 20, 16:00
More

Cosmo Pharmaceuticals Change in Payables and Accrued Expense (Quarterly)

Change in Payables and Accrued Expense (Quarterly) Chart

View Change in Payables and Accrued Expense (Quarterly) for CMOPF.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Change in Payables and Accrued Expense (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Change in Payables and Accrued Expense (Quarterly) Range, Past 5 Years

View Change in Payables and Accrued Expense (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Change in Payables and Accrued Expense (Quarterly) Benchmarks

View Change in Payables and Accrued Expense (Quarterly) Benchmarks
Start Trial
Amarin Corp. Plc Upgrade
Jazz Pharmaceuticals Plc Upgrade
Prothena Corp. Plc Upgrade
Iterum Therapeutics Plc Upgrade
GH Research Plc --